logical and biochemical features peculiar to GSH have been described. These include loss of the normal aldosterone response to Hypertension in childhood is uncommon angiotensin II infusion, excretion of large and secondary causes such as underlying amounts of the unusual 1 8-hydroxylated diseases of the kidney, coarctation of the aorta, steroids 1 8-hydroxycortisol and 1 8-oxocortisol or adrenal enzyme deficiency must be in urine, and an increase in plasma aldosexcluded. Glucocorticoid suppressible hyper-terone, 1 8-hydroxycortisol, and 1 8-oxocortisol aldosteronism (GSH) is such a secondary levels in response to corticotrophin (ACTH) disorder which can cause severe hypertension infusion, all of which are reversed by long term in young children. Presentation of GSH with treatment with glucocorticoids by mouth.2 acute renal failurel or as a cerebrovascular
Glucocorticoid suppressible hyperaldo-tension may be severe and associated with steronism (GSH) is an uncommon form end organ damage such as left ventricular of dominantly inherited hypertension. hypertrophy. The disorder is characterised by Presentation with hypertension and an autosomal dominant form of inheritance complications such as stroke in early life and features of hyperaldosteronism -that are well recognised. The use of a simple is, increased plasma aldosterone concengenetic test carried out on blood or trations, suppressed plasma renin concentraplacenta facilitates the detection ofinfants tion, often a low plasma potassium and children with GSH before the devel-concentration, and hypertension. No adrenal opment of hypertension, allowing prompt masses are found in GSH and administration treatment of hypertension if it occurs, of exogenous glucocorticoids, usually dexaand an opportunity to study the effects of methasone 2 mg/day for two to four weeks growth and environmental influences on results in a total reversal of these abnorthe progression of the condition.
malities. We describe the use of RFLP patterns in the rapid diagnosis of GSH in the perinatal period and in childhood in the children of subjects with GSH and discuss the implications of the early diagnosis of this disorder.
Methods
The father of the children in family 1 (II-3) described in the following was the subject of a previous study and his features and those of his siblings have been described elsewhere7; the children of family 1 Figure 2 shows the family tree with blood pressure data for the two families. Figure 3 shows the results of probing DNA digested with BamHI from the family members.
In family 1, RFLP analysis shows that both II-2 and II-3 are carriers of the chimaeric GSH gene. With reference to the family of the neonate, the mother (II-4) 
